Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 102
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Relapsed Hematologic Malignancy Trial in Seattle (Digital Health Coaching Program, Fitbit)

Recruiting
  • Multiple Myeloma
  • Relapsed Hematologic Malignancy
  • Digital Health Coaching Program
  • Fitbit
  • Seattle, Washington
    University of Washington
Jul 13, 2023

Multiple Myeloma Trial in United States (IGM-2644)

Recruiting
  • Multiple Myeloma
  • Duarte, California
  • +4 more
Jun 9, 2023

Acute Lymphoblastic Leukemia, Adult B-Cell, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in United States (clonoSEQ

Recruiting
  • Acute Lymphoblastic Leukemia, Adult B-Cell
  • +3 more
  • clonoSEQ Assay
  • Stanford, California
  • +15 more
Jan 30, 2023

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +189 more
Jan 27, 2023

Multiple Myeloma Trial in Spain, United States (BB2121, CC-220, BMS-986405)

Recruiting
  • Multiple Myeloma
  • BB2121
  • +2 more
  • Birmingham, Alabama
  • +33 more
Jan 26, 2023

Multiple Myeloma Trial in United States (Lenalidomide, Daratumumab/rHuPH20)

Recruiting
  • Multiple Myeloma
  • Anchorage, Alaska
  • +698 more
Jan 24, 2023

Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Birmingham, Alabama
  • +60 more
Jan 24, 2023

Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia Trial in United States (TTI-622, Azacitidine, Venetoclax)

Recruiting
  • Lymphoma
  • +3 more
  • Los Angeles, California
  • +36 more
Jan 23, 2023

Collection of Tissue Samples for Cancer Research

Recruiting
  • Neoplasms
  • +3 more
  • Biopsy
  • Atlanta, Georgia
  • +9 more
Jan 23, 2023

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +26 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +198 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab IV, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Placebo, Ixazomib)

Completed
Has Results
  • Multiple Myeloma
  • Fountain Valley, California
  • +274 more
Jan 13, 2023

Multiple Myeloma Trial in Worldwide (CC-220, Dexamethasone, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +126 more
Jan 10, 2023

Blood Samples to Identify Biomarkers of Busulfan

Active, not recruiting
  • Leukemia
  • +4 more
    • Seattle, Washington
      University of Washington
    Jan 4, 2023

    Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

    Recruiting
    • Waldenstrom Macroglobulinemia
    • +8 more
    • Iopofosine I 131 single dose
    • +2 more
    • Redlands, California
    • +42 more
    Dec 30, 2022

    Multiple Myeloma Trial in Worldwide (CC-99712, BMS-986405)

    Recruiting
    • Multiple Myeloma
    • La Jolla, California
    • +38 more
    Jan 3, 2023

    Multiple Myeloma Trial in Worldwide (ACY-241, Pomalidomide, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Tucson, Arizona
    • +24 more
    Dec 15, 2022

    Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)

    Active, not recruiting
    • Multiple Myeloma
    • bb2121
    • +8 more
    • Birmingham, Alabama
    • +59 more
    Dec 13, 2022

    Multiple Myeloma Trial in Worldwide (Pomalidomide, Bortezomib, Dexamethasone)

    Completed
    • Multiple Myeloma
    • Mobile, Alabama
    • +278 more
    Dec 6, 2022

    Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • Birmingham, Alabama
    • +125 more
    Nov 21, 2022

    Multiple Myeloma Trial in United States (CC-95266, Fludarabine, Cyclophosphamide)

    Recruiting
    • Multiple Myeloma
    • Birmingham, Alabama
    • +19 more
    Oct 11, 2022

    Multiple Myeloma Trial in Worldwide (ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone
    • Atlanta, Georgia
    • +25 more
    Aug 31, 2022

    Multiple Myeloma Trial in United States (SEA-BCMA, dexamethasone, pomalidomide)

    Recruiting
    • Multiple Myeloma
    • Palo Alto, California
    • +10 more
    Aug 24, 2022

    Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier Trial in Worldwide (CC-122)

    Active, not recruiting
    • Multiple Myeloma
    • +5 more
    • Duarte, California
    • +38 more
    Aug 18, 2022